Showing results (2471-2480 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|July 19, 2005
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cellsSabrina Ottaviani, Yi Zhang, Thierry Boon, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2005
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal typeChiara Pratesi, Maria Teresa Bortolin, Ettore Bidoli, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2005
The interplay between innate and adaptive immunity regulates cancer developmentK E de Visser, L M Coussens
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humansMarie Robin, Marie-Hélène Schlageter, Christine Chomienne, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
GD3-reactive antibodies can inhibit the lysis of autologous tumor cells by tumor-infiltrating lymphocytesE B Reilly, G Antognetti
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in ratsJin-Cherng Chen, Yun Chen, Jiann-Ming Wu, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigenPaul R Hess, David Boczkowski, Smita K Nair, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cellsFederico Avila-Moreno, José Sullivan López-González, Griselda Galindo-Rodríguez, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Adoptive T cell therapy of solid cancersKeith L Knutson, Wolfgang Wagner, Mary L Disis
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivoJan Schmidt, Christoph Klempp, Markus W Büchler, et al.
Pageof 652